Work

FDA requires expanded labeling about weight loss risk in patients younger than 6 years for extended‐release stimulants

Year: 2025

Type: article

Source: The Brown University Child & Adolescent Psychopharmacology Update

DOI: 10.1002/cpu.31005

Language: English

Topic: Attention Deficit Hyperactivity Disorder

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4413523089

FWCI:

Cites:

Cited by:

Related to: 10